Premier Alternatives

Oligomerix

Bronx, NY · Founded 2006 · Privately Held (backing)

Developer of small molecule therapeutics designed to treat Alzheimer's disease with an upstream approach. Oligomerix is based in Bronx, NY and was founded in 2006. It was valued at $11.1 million at its later-stage round in Mar 2022, the last priced event on record. It has raised $7.7 million across 2 recorded rounds; the latest was a $2.4 million seed round in Mar 2022.

PMV mark · valuation
$11.1M
Oct 2026
Priced at
its later-stage round
Mar 2022
Total raised
$7.7M
Last round
Seed Round
Mar 2022

Who backs Oligomerix?

5 investors
InvestorType
Counterview CapitalVenture capital
Alzheimers Drug Discovery Foundation—
Durand Venture Associates—
National Institute On Aging—
Wheatley Partners—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Oligomerix investors

5 investors are on record for Oligomerix, including Counterview Capital, Alzheimers Drug Discovery Foundation, Durand Venture Associates and National Institute On Aging. The seed round in Mar 2022 drew 12 investors.

Free account
More of Oligomerix with a free account
  • ·Watch Oligomerix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Oligomerix. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View